首页> 美国卫生研究院文献>other >Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer
【2h】

Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer

机译:明确的前瞻性立体定向消融放疗联合影像引导的调强放疗(IG-IMRT)或IG-IMRT单独用于局部晚期非小细胞肺癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundImage-guided (IG) intensity-modulated radiotherapy (IMRT) enables maximal tumor margin reduction for the sparing of organs at risk (OARs) when used to treat locally advanced non-small cell lung cancer (NSCLC) with definitive chemo-radiation. It also allows for the incorporation of stereotactic ablative radiotherapy (SABR) into the treatment regimen. Here, we describe our initial experience in combining definitive upfront SABR to the primary lesion with chemo-radiation delivered with conventionally fractionated IG-IMRT to the remaining regional disease; along with clinical outcome following chemo-radiation with conventionally fractionated IG-IMRT alone in the treatment of locally advanced NSCLC.
机译:背景技术图像引导(IG)强度调制放射疗法(IMRT)在用于定型化学放射治疗局部晚期非小细胞肺癌(NSCLC)时,可最大程度地减少肿瘤切缘,以减少风险器官(OAR)。它还允许将立体定向消融放疗(SABR)纳入治疗方案。在这里,我们描述了将原始的前期SABR与原发性病灶结合常规放疗的IG-IMRT与其余区域疾病进行化学放疗相结合的初步经验。以及常规局部分离的IG-IMRT进行化学放射治疗局部晚期NSCLC的临床结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号